article · International Journal for Equity in Health
BACKGROUND: Despite advancements in HIV management, healthcare inequalities continue to exist, especially in rural and populations vulnerable to HIV, where factors such as distance, low income, prejudice, and a shortage of healthcare workers contribute to delayed diagnosis and inadequate care. OBJECTIVE: This commentary explores how telemedicine can close the healthcare disparity gap for HIV patients in rural and vulnerable settings by bringing care closer and decreasing stigma. METHODS: The study analyzed primary sources, such as articles from PubMed, Science Direct, the Web of Science, and WHO reports from 2020 to 2024, including case studies, to examine the role of telemedicine in global HIV care. It assessed challenges, effectiveness, and infrastructural barriers, as well as policy implications. RESULTS: Telemedicine in HIV care for rural and vulnerable groups includes virtual consultation, monitoring, telehealth, digital health education, diagnostic services, telecounselling, telemental health, telepreventive care, and emergency services. It improves treatment involvement, reduces travel, ensures confidentiality, and reduces social disapproval. However, internet inefficiency and infrastructure issues in isolated regions hinder its use. CONCLUSION: Telemedicine effectively addresses HIV care gaps in rural and high-risk populations by increasing service utilization, reducing stigma, and improving patient care quality; however, long-term sustainability requires infrastructure improvements and internet connectivity issues.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12939-025-02584-2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.